Multiple inflammatory and signaling targets

Multiple inflammatory and signaling targets is a collective term rather than a specific, individual molecular entity. It refers to a broad pharmacological approach where a therapeutic agent modulates several distinct proteins, such as cytokines, kinases, and transcription factors, to achieve an anti-inflammatory effect (Source: PubMed, PMID: 30237540). This profile is characteristic of pleiotropic drugs like corticosteroids or multi-kinase inhibitors that do not rely on a single lock-and-key interaction but instead influence entire signaling networks like the NF-kappaB or MAPK pathways (Source: StatPearls, Inflammation). Because it encompasses a wide variety of unrelated proteins, it is considered an imprecise or overly broad designation for a therapeutic target in a structured biochemical context (Source: Nature Reviews Drug Discovery, 2019). Such multi-target strategies are often employed in treating complex systemic diseases where a single-target approach may be insufficient, though they carry a higher risk of off-target effects and systemic toxicity (Source: NIH, PubChem). In clinical research, this term may be used to describe the activity of botanical extracts or legacy drugs whose exact molecular mechanism involves a network of interactions rather than a single binding event.

Other names

Multi-target inflammatory mediatorsPolypharmacological targetsInflammatory signaling networkPleiotropic targets

Pleiotropic modulation of multiple signaling cascades and inflammatory mediators, including the inhibition of pro-inflammatory transcription factors and the downregulation of various cytokines (Source: PubMed, PMID: 30237540).